• 24 Apr, 2025

JuveXO® Unveils Verified Exosome Images, Setting a New Standard in Transparency and Scientific Proof in Cosmetics

JuveXO® Unveils Verified Exosome Images, Setting a New Standard in Transparency and Scientific Proof in Cosmetics

MIAMI, April 22, 2025 -- The scientific team at JuveXO®, one of the most advanced exosome-based solutions available today, is thrilled to announce the first images of exosomes - an incredible achievement that positions JuveXO® at the forefront of biocosmetic discovery. Born from decades of research and innovation by Chief Development & Science Officer (CDSO) Rafael Gonzalez, PhD, a leading figure in cell therapy research, and the scientists behind JuveXO® have fully characterized their exosomes and gone above and beyond to show off their superior exosome product. JuveXO boasts billions of exosomes in each of its vials as well as naturally occurring High Molecular Weight Hyaluronic Acid, Collagen I and III, Glutathione, Biotin, Peptides, and Growth Factors. JuveXO is used topically for hair and skin rejuvenation post aesthetic treatments such as microneedling, RF (radiofrequency) laser, CO2 laser, hair restoration procedures, and chemical peels, enhancing recovery and optimizing results. https://juvexo.com/blogs/articles/breaking-ground-juvexos-first-image-of-an-exosome-a-new-era-in-scientific-visualization

JuveXO® releases verified exosome images—setting a new benchmark for scientific proof in aesthetics.

But first, what are exosomes? Exosomes are small extracellular vesicles that play a pivotal role in intercellular communication, serving as vehicles for the transport of various biomolecules such as proteins, lipids, and nucleic acids between cells. Exosome technology has garnered significant attention in recent years due to their multifaceted functions and profound implications. JuveXO® is the first biocosmetic company to image exosomes both in frozen vials and following lyophilization using advanced electron microscopy techniques, the correct approach to visualizing an exosome and demonstrating its presence. The ability to visualize exosomes with such precision gives JuveXO® a significant competitive advantage over other players in the biocosmetic sector.

With research on optimal biocosmetic formulations stemming back to 2014, JuveXO® stands out as a distinctive scientific leader in the rapidly evolving field of biocosmetics space. JuveXO®'s umbilical cord lining stem cells (ULSCs) are superior to a standard MSC, were specifically researched and designed for the biocosmetic space—offering optimal results for the skin. 

Chief Development & Science Officer (CDSO) Rafael Gonzalez, PhD of JuveXO® says, "It's a groundbreaking time for all of us at JuveXO® who have dedicated so much research, time and resources perfecting our product. The ability to visualize exosomes with such precision gives JuveXO® a significant competitive advantage over other players in the biocosmetic and aesthetic sectors. The imaging technology that JuveXO® employs represents a significant leap forward in the field of aesthetics, enabling practitioners to see that the product truly does contain exosomes. This helps them trust the products they are providing to patients."

While the ability to visualize exosomes decades ago marked a significant breakthrough in biomedical research for new scientific innovations, many exosome-derived products lacked rigorous validation until recently. Adopting advanced imaging methods has allowed researchers at JuveXO® to deepen their understanding of the exosome. Today, as numerous brands enter the market with claims of including exosomes in their products, the leaders at Congela Biocosmetics, the distributor of JuveXO, are raising the bar for industry transparency. By conclusively proving the presence of exosomes in our products, we invite others to meet this new standard of verification. Our message to the industry is straightforward: "We've shown you ours, now you show us yours."

To prove their presence and integrity in products, JuveXO® has embraced the standards set by the International Society for Extracellular Vesicles (ISEV), which recommends specific techniques for confirming exosome presence, such as nanoparticle tracking analysis, tunable resistive pulse sensing, and electron microscopy amongst other marker expressions that need to be present. Electron microscopy, specifically, allows for the direct observation of exosomes, showcasing their size, shape, and the integrity of their bilipid layers, which are crucial for their functionality.

Utilizing state-of-the-art equipment and methodologies, researchers can accurately observe exosomes on a nanoscale level, pinpointing their presence and concentration in biological samples that lead to deeper scientific insights. By adhering to these ISEV-endorsed techniques and especially employing electron microscopy, JuveXO® not only substantiates the presence of genuine exosomes in their products but also ensures they remain intact and functional from production to delivery. This adherence to the highest scientific standards establishes a new benchmark in product transparency and trust, pioneering a standard that should define the future of regenerative medicine and cosmetic industries alike.

ABOUT JuveXO®
JuveXO® is a high-quality umbilical cord lining stem cell (ULSCs) product that is superior to standard MSC-derived secretome products. We have a patent-pending technology that enables control of the protein type released by ULSCs. With more than ten years of research, JuveXO® has been specially designed to contain high amounts of naturally occurring Types I and III Collagen, Biotin, Gluthathione, Chondroitin Sulfate, Growth Factors, and High-Molecular-Weight Hyaluronic Acid, making JuveXO® the leader in cosmetic use. Our premium serum line is produced from vigorously tested, postnatal ULSCs and is pre-COVID and cell-free. JuveXO® offers a comprehensive exosome portfolio, including:

  • JuveXO® Pro – A multi-dose vial designed for professional aesthetic skincare treatments that boasts 50 billion exosomes per mL.
  • JuveXO® Pro H – Developed specifically for scalp and hair restoration applications with 50 billion exosomes per mL.
  • JuveXO® Lyo – A lyophilized formula with 25 billion exosomes per vial that can be reconstituted to service up to 5 patients, offering greater flexibility and convenience.

JuveXO products are developed in an FDA-registered laboratory which follows good manufacturing practices, ensuring the highest standards of quality, safety, and compliance. Our commitment to excellence is underscored by adherence to rigorous regulatory standards and ethical practices, providing practitioners and consumers with trusted and effective biocosmetic solutions. To find a provider near you, visit JuveXO.com. If you are a physician interested in becoming a provider, visit https://juvexo.com/account/register.

For more information or interviews requests, please contact:
Creative Media Marketing | juvexo@cmmpr.com

This News is brought to you by Qube Mark, your trusted source for the latest updates and insights in marketing technology. Stay tuned for more groundbreaking innovations in the world of technology. 

PR Newswire

PR Newswire empowers communicators to identify and engage with key influencers, craft and distribute meaningful stories, and measure the financial impact of their efforts. Cision is a leading global provider of earned media software and services to public relations and marketing communications professionals.